CD8A and lymphoma: Similar results were obtained from a murine tumor-bearing mice model in vivo, in which OVA-expressing lymphoma cell line E.G7 cells were transplanted and introduced antitumor responses by CD8+ T cells from OT-I TCR-Tg mice.